BioStock: Stayble Therapeutics’ SAB strengthened with two top names

Stayble Therapeutics has strengthened its scientific advisory board (SAB) with two knowledgeable and reputable members - Dr Aaron Calodney and Dr Douglas Beall. They will contribute their knowledge and experience within pain management and spine-related issues as well as bring an important US perspective. BioStock contacted the company's Chief Scientific Officer (CSO) Anders Lehmann regarding the new recruits.

Read the full article at
This is a press release from BioStock - Connecting Innovation & Capital.